Patient Rights · Last reviewed 2026-05-13

Patient Bill of Rights

Your rights as a patient at Irvine Health. Read this carefully. Print it. Refer to it whenever you need to.

Aligned with the American Hospital Association Patient Care Partnership, HIPAA, applicable state law, and FDA off-label and compounding regulations. Compliance reviewed by the Irvine Health clinical team.

In one paragraph

You have the right to know what we are prescribing and why; to know the FDA status of every medication (approved, compounded off-label, or investigational); to give or withhold informed consent at any time; to access your records, refuse treatment, change your mind, and have any concern addressed within five business days. Some peptides we discuss are not FDA-approved and are legally compounded for off-label use under physician supervision — we tell you this explicitly on every product page and require written consent before dispensing. If we fail any of these obligations, contact us; if we still fall short, you have the right to escalate to state medical boards, the FDA MedWatch program, and the Office for Civil Rights.

Your Rights

  1. Right to informed consent
  2. Right to know FDA status
  3. Right to understand off-label prescribing
  4. Right to physician evaluation
  5. Right to refuse or stop treatment
  6. Right to access your medical records
  7. Right to privacy (HIPAA)
  8. Right to know your pharmacy
  9. Right to transparent pricing
  10. Right to a second opinion
  11. Right to non-discriminatory care
  12. Right to raise concerns
  13. Right to report adverse events
  14. Right to data portability
  15. Right to interpretation services
02

Right to know FDA status

You have the right to know, before any prescription is dispensed, the specific FDA regulatory status of every medication you may receive. We classify every peptide we discuss into one of three categories:

FDA-approved. Examples: semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Zepbound, Mounjaro), liraglutide (Saxenda, Victoza), tesamorelin (Egrifta), bremelanotide (Vyleesi). These have completed FDA Phase I, II, and III clinical trials for at least one indication and are manufactured under cGMP standards.
Compounded, prescribed off-label. Examples: BPC-157, CJC-1295, ipamorelin, TB-500, thymosin alpha-1, semax, selank, GHK-Cu, kisspeptin-10. These are not FDA-approved as commercial drugs. They may be legally compounded by licensed 503A pharmacies for individual patients with a valid prescription from a licensed prescriber, under FDA's compounding framework. Long-term human safety data is limited.
Investigational. Examples: retatrutide and other peptides in active Phase 2/3 development. Irvine Health does not prescribe investigational peptides. These are only available within registered clinical trials at qualified research institutions.
03

Right to understand off-label prescribing

"Off-label" means a physician is prescribing a medication for a condition, dose, or patient population for which the FDA has not specifically approved that medication. Off-label prescribing is legal in the United States and is common across many specialties; it is the basis for most compounded peptide therapy.

You have the right to know whether your prescription is off-label, why your physician believes it is appropriate for you specifically, and what published evidence supports that decision. For most compounded peptides, the evidence base is preclinical (animal studies); for some it includes limited human clinical data; for none does it match the rigor of FDA-approved branded indications. We will tell you this honestly before you decide.

04

Right to a real physician evaluation

You have the right to a real evaluation by a US-licensed physician before any prescription is issued. This includes:

You have the right to know the name, state of licensure, and NPI of the physician evaluating you. Irvine Health affiliated physicians must be licensed in the state where you reside.

05

Right to refuse or stop treatment

You have the absolute right to refuse any prescribed treatment, to stop a treatment at any time, and to switch to a different protocol. You do not need to justify your decision. If stopping a medication abruptly is medically inadvisable (e.g., taper required), your physician will explain a safe discontinuation plan, but the final decision remains yours.

Refusal of any one treatment will not affect your access to other treatments or your standing as a patient.

06

Right to access your medical records

Under HIPAA, you have the right to request, review, and receive copies of your complete medical records held by Irvine Health, including:

Records will be provided within 30 days of a written request (extendable once by 30 days under HIPAA). You have the right to receive records in the format you request when reasonably available (electronic, paper, or specific file format). You also have the right to request corrections to any information you believe is incorrect.

07

Right to privacy (HIPAA)

Your protected health information (PHI) is private. Irvine Health does not sell, rent, or share your PHI for marketing without your written authorization. PHI is shared with:

All vendors that receive your PHI operate under a Business Associate Agreement (BAA). You have the right to request a list of disclosures of your PHI over the prior six years. See our Notice of Privacy Practices for full details.

08

Right to know your pharmacy

You have the right to know the name, state license, and accreditation status of the compounding pharmacy that will prepare your medication. You may request:

09

Right to transparent pricing

You have the right to know the full price of any treatment before you commit. This includes:

You have the right to a written itemized statement of every charge. We do not bill in advance of services and we do not charge cancellation fees prior to physician evaluation.

10

Right to a second opinion

You have the right to seek a second opinion from any other licensed healthcare provider at any time and to share your Irvine Health records with that provider at no cost. We will not delay or interfere with your access to other providers.

11

Right to non-discriminatory care

Irvine Health does not discriminate in clinical evaluation or treatment decisions on the basis of race, color, national origin, religion, sex, gender identity, sexual orientation, age, disability, marital status, or veteran status. Clinical decisions are based solely on medical appropriateness, evidence, and patient goals.

12

Right to raise concerns

You have the right to raise any concern about your care, your privacy, your bill, or your physician without fear of retaliation. Concerns will be:

If you are not satisfied with our internal response, you have the right to escalate to:

13

Right to report adverse events

If you experience a side effect, unexpected reaction, or any harm you believe is related to a medication, you have the right to report it. You should:

We are required to record adverse events in our compliance log and may be required to report certain events to FDA or state authorities. We will tell you when we do so. Reporting an adverse event will not affect your standing as a patient.

14

Right to data portability and deletion

You have the right to receive a portable electronic copy of your data (clinical records, billing history, treatment history) on request. Once a treatment relationship has ended and the legal retention period for medical records has elapsed (typically 7–10 years per state law), you may request deletion of personal information held outside of legally required retention.

15

Right to interpretation services

If English is not your primary language, you have the right to request interpretation services at no cost during your physician consultation. The Irvine Health platform is available in English and Spanish. Additional language support can be arranged on request.

General concerns or feedback

Email [email protected]. Acknowledged within two business days; addressed within five.

Adverse event or safety concern

Email [email protected] immediately. For emergencies, call 911 first. Report to FDA MedWatch in parallel: FDA MedWatch.

Privacy / HIPAA concern

Email [email protected] or escalate to HHS Office for Civil Rights.

Records request

Email [email protected]. Records provided within 30 days under HIPAA.